BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/11/2024 2:23:39 AM | Browse: 9 | Download: 9
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 91523
Country Brazil
Received
2023-12-29 21:07
Peer-Review Started
2023-12-29 21:07
To Make the First Decision
Return for Revision
2024-01-20 06:20
Revised
2024-01-26 19:58
Second Decision
2024-03-04 02:52
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2024-03-04 05:18
Articles in Press
2024-03-04 05:18
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2024-03-27 05:36
Publish the Manuscript Online
2024-04-11 02:23
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Review
Article Title New avenues for the treatment of immunotherapy-resistant pancreatic cancer
Manuscript Source Invited Manuscript
All Author List Luis Guilherme de Oliveira Silva, Fabian Fellipe Bueno Lemos, Marcel Silva Luz, Samuel Luca Rocha Pinheiro, Mariana dos Santos Calmon, Gabriel Lima Correa Santos, Gabriel Reis Rocha and Fabrício Freire de Melo
ORCID
Author(s) ORCID Number
Luis Guilherme de Oliveira Silva http://orcid.org/0000-0001-7275-7182
Fabian Fellipe Bueno Lemos http://orcid.org/0000-0002-4686-7086
Marcel Silva Luz http://orcid.org/0000-0003-1650-5807
Samuel Luca Rocha Pinheiro http://orcid.org/0000-0002-8877-892X
Mariana dos Santos Calmon http://orcid.org/0000-0002-3871-7408
Gabriel Lima Correa Santos http://orcid.org/0000-0003-3673-9889
Gabriel Reis Rocha http://orcid.org/0000-0002-3090-0726
Fabrício Freire de Melo http://orcid.org/0000-0002-5680-2753
Funding Agency and Grant Number
Funding Agency Grant Number
The Scientific Initiation Scholarship Programme (PIBIC) of National Council for Scientific and Technological Development 6511185733054315
The Scientific Initiation Scholarship Programme (PIBIC) of National Council for Scientific and Technological Development 3748771590681149
The Scientific Initiation Scholarship Programme (PIBIC) of Bahia State Research Support Foundation 19.573.301.5418
The CNPq Research Productivity Fellow 4357511882624145
Corresponding Author Fabrício Freire de Melo, PhD, Professor, Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Rua Hormínio Barros, No. 58, Candeias, Vitória da Conquista 45029-094, Bahia, Brazil. freiremelo@yahoo.com.br
Key Words Pancreatic cancer; Immunotherapy; Resistance; Tumor microenvironment; manipulation; Combined immunotherapy
Core Tip This study aims to analyze the main mechanisms of resistance to pancreatic cancer immunotherapy and the respective methods of manipulating these processes. Thus, this review provides a compilation of the main mechanisms of resistance to immunotherapy linked to the tumor microenvironment, genetic factors and those linked to T-cell immunosuppression. Finally, this study provides an insight into new avenues that can be followed to manipulate the factors linked to resistance, providing a more efficient treatment and a reduction in lethality.
Publish Date 2024-04-11 02:23
Citation Silva LGO, Lemos FFB, Luz MS, Rocha Pinheiro SL, Calmon MDS, Correa Santos GL, Rocha GR, de Melo FF. New avenues for the treatment of immunotherapy-resistant pancreatic cancer. World J Gastrointest Oncol 2024; 16(4): 1134-1153
URL https://www.wjgnet.com/1948-5204/full/v16/i4/1134.htm
DOI https://dx.doi.org/10.4251/wjgo.v16.i4.1134
Full Article (PDF) WJGO-16-1134-with-cover.pdf
Manuscript File 91523_Auto_Edited-YJP.docx
Answering Reviewers 91523-Answering reviewers.pdf
Audio Core Tip 91523-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 91523-Conflict-of-interest statement.pdf
Copyright License Agreement 91523-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 91523-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate 91523-Language certificate.pdf
Peer-review Report 91523-Peer-review(s).pdf
Scientific Misconduct Check 91523-Bing-Liu H-2.png
Scientific Editor Work List 91523-Scientific editor work list.pdf